Dhananjay Chitale

<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib

James Bean, Cameron Brennan, Jin‐Yuan Shih et al. · Proceedings of the National Academy of Sciences · 2007 · 1.6K citations

Harbors Met Amplification, Engineering, Pathology +18

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley et al. · Journal of Thoracic Oncology · 2013 · 1.3K citations · Full text

Frequency and Distinctive Spectrum of <i>KRAS</i> Mutations in Never Smokers with Lung Adenocarcinoma

Gregory J. Riely, Mark G. Kris, Daniel G. Rosenbaum et al. · Clinical Cancer Research · 2008 · 559 citations · Full text

Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for <i>BRAF, PIK3CA</i> , and <i>AKT1</i>

Julio C. Ricarte‐Filho, Mabel Ryder, Dhananjay Chitale et al. · Cancer Research · 2009 · 521 citations · Full text

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley et al. · Journal of Molecular Diagnostics · 2013 · 456 citations